In some certain types of cancer, specific tumor markers, for instance, alpha‐fetoprotein in hepatic carcinoma and PSA in prostate cancer, have shown high sensitivity and specificity for specific tumor types, which provides valuable clues for identifying the primary site for CUP. This evidence concerns the gene AFP and hepatocellular carcinoma.